Cybin (AMEX:CYBN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cybin (CYBN) operate in?

Cybin is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.

Cybin Stock (AMEX: CYBN) stock price, news, charts, stock research, profile.

Open	$0.29
Close	-
Volume / Avg.	4.62M / 4.10M
Day Range	0.27 - 0.29
52 Wk Range	0.25 - 0.74
Market Cap	$205.13M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	23
Short Interest	10.37%
Days to Cover	3.2

Recent News

Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development

Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now!

Patricio Liddle

Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More

As the premier gathering of top entrepreneurs and investors is taking place this Monday in New Jersey, let's scroll through the latest leadership changes in the cannabis and psychedelics industries.Cybin Inc.announced recently that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, opted to join the company as senior vice president of clinical development. In addition, six cannabis companies announced changes to their respective boards of directors.

Jelena Martinovic

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.

Aaron Bry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for pa...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cybin (CYBN) stock?

You can purchase shares of Cybin (AMEX:CYBN) through any online brokerage.

View our list of the best stock brokerages

Who are Cybin (CYBN) competitors?

There are no as such competitors for Cybin.

What is the target price for Cybin (CYBN) stock?

There is no analysis for Cybin.

What is the forecast for Cybin (CYBN) stock?

Cybin has a consensus price target of $2.83.

Current stock price for Cybin (CYBN)?

The stock price for Cybin (AMEX: CYBN) is $0.27 last updated Today at June 28, 2024 at 11:42 AM EDT.

Does Cybin (CYBN) pay a dividend?

There are no upcoming dividends for Cybin.

When is Cybin (AMEX:CYBN) reporting earnings?

Cybin’s Q1 earnings are confirmed for Monday, August 12, 2024.

Is Cybin (CYBN) going to split?

There is no upcoming split for Cybin.

What sector and industry does Cybin (CYBN) operate in?

Cybin is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cybin

Cybin (CYBN) Forecast